A phase 3 trial of Priovant Therapeutics’ inflammatory disease prospect brepocitinib has hit its primary endpoint, setting ...

Formation Bio, the AI-native pharmaceutical company revolutionizing drug development, today announced the appointment of four world-class leaders to its senior team: Louis Brenner, MD, as Chief ...

NAPLES, Fla., Aug. 12, 2025 /PRNewswire/ -- MC Sciences, an emerging biotech developing first-in-class novel therapeutics backed by ROC Venture Group, proudly announces the appointment of Dr. Mikael ...

Bourla praised Trump’s “profound” handling of the 2020 Covid-19 vaccine rollout during his first admin as work worthy of his much-coveted Nobel Peace Prize. The post Pfizer CEO Floats ‘Warp Speed’ ...